Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1997 • 1,621 citations

Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate Cancer

1997 • 1,140 citations

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

1999 • 907 citations

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.

1993 • 400 citations

Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer

1999 • 398 citations

Nomogram for Overall Survival of Patients With Progressive Metastatic Prostate Cancer After Castration

2002 • 388 citations

Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

2001 • 327 citations

Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma

1997 • 243 citations

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.

1994 • 225 citations

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

1998 • 223 citations

The bootstrap and identification of prognostic factors via cox's proportional hazards regression model

1985 • 209 citations

Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer

1999 • 169 citations

THE COMBINATION OF PREOPERATIVE PROSTATE SPECIFIC ANTIGEN AND POSTOPERATIVE PATHOLOGICAL FINDINGS TO PREDICT PROSTATE SPECIFIC ANTIGEN OUTCOME IN CLINICALLY LOCALIZED PROSTATE CANCER

1998 • 166 citations

Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.

2001 • 158 citations

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

1979 • 140 citations

Clinical Trials in Relapsed Prostate Cancer: Defining the Target

1996 • 129 citations

Prognostic factors in patients with advanced stage prostate cancer.

1985 • 123 citations

OUTCOME BASED STAGING FOR CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATE

1997 • 102 citations

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.

1995 • 101 citations

BIOSTATISTICAL MODELING USING TRADITIONAL PREOPERATIVE AND PATHOLOGICAL PROGNOSTIC VARIABLES IN THE SELECTION OF MEN AT HIGH RISK FOR DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER

1998 • 96 citations

A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma

2000 • 85 citations

Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy

1997 • 81 citations

Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy

1992 • 58 citations

Prognostic Significance of Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen in Metastatic Prostate Cancer: A Nested Study Within CALGB 9583

2003 • 56 citations

Randomized Study of Three Different Doses of Suramin Administered With a Fixed Dosing Schedule in Patients With Advanced Prostate Cancer: Results of Intergroup 0159, Cancer and Leukemia Group B 9480

2002 • 55 citations

Prognostic Significance of Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen in Men With Hormone-Refractory Prostate Cancer

2001 • 55 citations

A comparative clinical trial of adriamycin and 5‐fluorouracil in advanced prostatic cancer: Prognostic factors and response

1983 • 48 citations

Prognostic factors in patients with advanced prostate cancer

1989 • 46 citations

PROGNOSTIC INDICATORS IN HORMONE REFRACTORY PROSTATE CANCER

1999 • 35 citations

Higher doses of mitoxantrone among men with hormone‐refractory prostate carcinoma

2002 • 17 citations

HYDROCORTISONE (H) WITH OR WITHOUT MITOXANTRONE (M) IN MEN WITH HORMONE REFRACTORY PROSTATE CANCER (HRPC). THE RESULTS OF CALGB 9182

1999 • 17 citations

Serum Prostate Specific Antigen as a Predictor of Survival in Prostate Cancer Patients Treated with Second‐Line Hormonal Therapy (CALGB 9181)

2001 • 6 citations

Cited By (0)

No citing papers found in database